About InSilixa
InSilixa is a company based in Sunnyvale (United States) founded in 2012 by Arjang Hassibi. It operates as a B2B. InSilixa has raised $13 million across 2 funding rounds from investors including HHS, PointGuard Ventures and Morningside. The company has 40 employees as of December 31, 2022. InSilixa operates in a competitive market with competitors including Cepheid, Prenetics, Karius, Day Zero Diagnostics and OpGen, among others.
- Headquarter Sunnyvale, United States
- Employees 40 as on 31 Dec, 2022
- Founders Arjang Hassibi
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Insilixa, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13 M (USD)
in 2 rounds
-
Latest Funding Round
$13 M (USD), Series A
Oct 22, 2014
-
Investors
HHS
& 2 more
-
Employee Count
40
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of InSilixa
Unlock access to complete
Funding Insights of InSilixa
InSilixa has successfully raised a total of $13M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $13 million completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in InSilixa
InSilixa has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, PointGuard Ventures and Morningside.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage technology investments are made by PointGuard Ventures.
|
Locked | Locked | Locked | |
|
Multiple sectors are invested in by Morningside, a VC fund.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for InSilixa
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InSilixa
Investment portfolio details for InSilixa
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InSilixa
Detailed financials for InSilixa
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Insilixa Comparisons
Peer comparison for InSilixa
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InSilixa
InSilixa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Prenetics, Karius, Day Zero Diagnostics and OpGen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Food safety technologies are provided for pathogen identification.
|
Detailed competitors of InSilixa
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Insilixa
Complete news archive for InSilixa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InSilixa
InSilixa was founded in 2012 and raised its 1st funding round 1 year after it was founded.
InSilixa is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Arjang Hassibi is the current CEO of InSilixa. They have also founded this company.
InSilixa is a funded company, having raised a total of $13M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at InSilixa is 40.
InSilixa, founded in 2012 in Sunnyvale, United States, focuses on providing healthcare solutions, developing medical devices, offering diagnostic solutions, and point-of-care. Develops innovative point-of-care diagnostics using semiconductor-based CMOS biochip technology. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
InSilixa's top competitors include Cepheid, Prenetics and Clear Labs.
InSilixa has 3 investors. Key investors include HHS, PointGuard Ventures, and Morningside.